These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15762974)

  • 1. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
    Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
    Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
    Bouwmeester FW; Jonkhoff AR; Verheijen RH; van Geijn HP
    Obstet Gynecol; 2003 Jun; 101(6):1174-6. PubMed ID: 12798521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case of massive postoperative hemorrhage after hysterectomy and successful application of Novo-Seven].
    Velev R; Nenov V; Dacheva R; Vŭtev P
    Akush Ginekol (Sofiia); 2006; 45 Suppl 2():19-22. PubMed ID: 16922341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
    Michalska-Krzanowska G
    Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
    Holub Z; Feyereisl J; Kabelík L; Rittstein T
    Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
    Lim Y; Loo CC; Chia V; Fun W
    Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired hemophilia as a cause of primary postpartum hemorrhage.
    Borna S; Hantoushzadeh S
    Arch Iran Med; 2007 Jan; 10(1):107-10. PubMed ID: 17198466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
    Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
    Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of recombinant activated FVII in postpartum hemorrhage.
    Franchini M; Franchi M; Bergamini V; Montagnana M; Salvagno GL; Targher G; Lippi G
    Clin Obstet Gynecol; 2010 Mar; 53(1):219-27. PubMed ID: 20142658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of recombinant factor VIIa on the therapy of massive bleeding after cesarean section].
    Uharcek P; Mlyncek M; Kellner M; Lajtman E
    Ceska Gynekol; 2007 May; 72(3):200-2. PubMed ID: 17616074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
    Matei A; Dolan S; Andrews J; Rivard GÉ
    J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
    Heilmann L; Wild C; Hojnacki B; Pollow K
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
    Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
    Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.